Relationship between peptide binding and T cell epitope selection: A study with subtypes of HLA-B27

International Immunology

Volumn 10, Issue 3, 1998, Pages 259-266

  Lamas, José R ^a   Brooks, Jill M ^b   Galocha, Begoña ^a   Rickinson, Alan B ^b   López De Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Epstein Barr virus; HLA B27; Peptide binding; Viral epitopes

Indexed keywords

ARGININE; EPITOPE; HLA B27 ANTIGEN; PEPTIDE; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGENICITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOGENICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN PRESENTATION; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HLA-B27 ANTIGEN; HUMANS; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031914437     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.3.259     Document Type: Article

References (34)

1. Garrett, T. P., Saper, M. A., Bjorkman, P. J., Strominger, J. L. and Wiley, D. C. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692.
2. Parham P., Adams, E. J. and Arnett, K. L. 1995. The origins of HLA-A, B, C polymorphism. Immunol. Rev. 143:141.
3. *2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J. Immunol. 152:5557.
4. Lopez de Castro, J. A. 1995. Structural polymorphism and function of HLA-B27. Curr. Opin. Rheumatol. 7:270.
5. *2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket. Tissue Antigens 49:580.
6. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R. and Wiley, D. C. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
7. *2703 allelic variants: implications for susceptibility to spondylarthropathies. J. Clin. Invest. 98:2764.
8. *2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 51:1.
9. *2705 peptide motifs. Immunogenetics 39:74.
10. Fiorillo, M. T., Meadows, L., D'Amato, M., Shabanowitz, J., Hunt, D. F., Apella, E. and Sorrentino, R. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol 27:368.
11. *2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 49:215.
12. *2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. Immunogenetics 47:103.
13. Lopez de Castro, J. A. 1989. HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol. Today 10:239.
14. Zinkernagel, R. M. and Doherty, P. C. 1974. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251:547.
15. Townsend, A. and Bodmer, H. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
16. Brooks, J. M., Murray, R. J., Thomas, W. A., Kurilla, M. G. and Rickinson, A. B. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879.
17. Silver, M. L., Guo, H. C., Strominger, J. L. and Wiley, D. C. 1992. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360:367.
18. *2703. Eur. J. Immunol. 25:2370.
19. *2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 48:509.
20. Ellis, S. A., Taylor, C. and McMichael, A. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5:49.
21. Hill, A. B., Lee, S. P., Haurum, J. S., Murray, N., Yao, Q. Y., Rowe, M., Signoret, N., Rickinson, A. B. and McMichael, A. J. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J. Exp. Med. 181:2221.
22. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J., et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586,
23. van der Burg, S. H., Visseren, M. J., Brandt, R. M., Kast, W. M. and Melief, C. J. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308.
24. Levitsky, V., Zhang, Q. J., Levitskaya, J. and Masucci, M. G. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915.
25. Deng, Y., Yewdell, J. W., Eisenlohr, L. C. and Bennink, J. R. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
26. Lopez-Larrea, C., Sujirachato, K., Mehra, N. K., Chiewsilp, P., Isarangkura, D., Kanga, U., Dominguez, O., Coto, E., Pena, M., Setien, F. and Gonzalez-Roces, S. 1995. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 45:169.
27. D'Amato, M., Fiorillo, M.T., Carcassi, C., Mathieu, A., Zuccarelli, A., Bitti, P. P., Tosi, R. and Sorrentino, R. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J. Immunol. 25:3199.
28. Nasution, A. R., Mardjuadi, A., Kunmartini, S., Suryadhana, N. G., Setyohadi, B., Sudarsono, D., Lardy, N. M. and Feltkamp, T. E. 1997. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J. Rheumatol. 24:1111.
29. Breur-Vriesendorp, B. S., Dekker Saeys, A. J. and Ivanyi, P. 1987. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann. Rheum. Dis. 46:353.
30. + T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. J. Immunol. 157:4464.
31. Simmons, W. A., Summerfield, S. G., Roopenian, D. C., Slaughter, C. A., Zuberi, A. R., Gaskell, S. J., Bordoli, R. S., Hoyes, J., Moomaw, C. R., Colbert, R. A., Leong, L. Y. W., Butcher, G, W., Hammer, R. E. and Taurog, J. D. 1997. Novel HY peptide antigens presented by HLA-B27. J. Immunol. 159:2750,
32. Parker, K. C., Biddison, W. E. and Coligan, J. E. 1994. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. Biochemistry 33:7736.
33. Fukazawa, T., Wang, J., Huang, F., Wen, J., Tyan, D., Williams, K.M., Raybourne, R. B. and Yu, D. T. 1994. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies. J. Immunol. 152:1190.
34. *2702. Protein Sci. 5:2080.